journal article·2020-01-01Open access

c(RGDyk)-modified nanoparticles encapsulating quantum dots as a stable fluorescence probe for imaging-guided surgical resection of glioma under the auxiliary UTMD

Qi-Long Wu, He-Lin Xu, Cui Xiong, Qing-Hua Lan, Ming-Ling Fang, Jin-Hua Cai, Hui Li, Shu-Ting Zhu, Jing-Hong Xu, Fang-Yi Tao, Cui-Tao Lu, Ying-Zheng Zhao, Bin Chen

Abstract

Surgical resection remains the preferred approach for some patients with glioblastoma (GBM), and eradication of the residual tumour niche after surgical resection is very helpful for prolonging patient survival. However, complete surgical resection of invasive GBM is difficult because of its ambiguous boundary. Herein, a novel targeting material, c(RGDyk)-poloxamer-188, was synthesized by modifying carboxyl-terminated poloxamer-188 with a glioma-targeting cyclopeptide, c(RGDyk). Quantum dots (QDs) as fluorescent probe were encapsulated into the self-assembled c(RGDyk)-poloxamer-188 polymer nanoparticles (NPs) to construct glioma-targeted QDs-c(RGDyk)NP for imaging-guided surgical resection of GBM. QDs-c(RGDyk)NP exhibited a moderate hydrodynamic diameter of 212.4 nm, a negative zeta potential of –10.1 mV and good stability. QDs-c(RGDyk)NP exhibited significantly lower toxicity against PC12 and C6 cells and HUVECs than free QDs. Moreover, in vitro cellular uptake experiments demonstrated that QDs-c(RGDyk)NP specifically targeted C6 cells, making them display strong fluorescence. Combined with ultrasound-targeted microbubble destruction (UTMD), QDs-c(RGDyk)NP specifically accumulated in glioma tissue in orthotropic tumour rats after intravenous administration, evidenced by ex vivo NIR fluorescence imaging of bulk brain and glioma tissue sections. Furthermore, fluorescence imaging with QDs-c(RGDyk)NP guided accurate surgical resection of glioma. Finally, the safety of QDs-c(RGDyk)NP was verified using pathological HE staining. In conclusion, QDs-c(RGDyk)NP may be a potential imaging probe for imaging-guided surgery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Quantum Dots Synthesis And Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Ultrasonography, The First Affiliated Hospital of Wenzhou Medical University

Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical University

Funding

Zhejiang Provincial Natural Science Foundation · Wenzhou Science and Technology Bureau

References (65)

Show source-provided references
1. 10.1016/j.cell.2012.03.00910.1016/j.cell.2012.03.009 ↗
2. 10.1124/pr.117.01494410.1124/pr.117.014944 ↗
3. 10.1080/13543784.2018.152822510.1080/13543784.2018.1528225 ↗
4. 10.1097/MD.000000000000005710.1097/MD.0000000000000057 ↗
5. 10.3389/fonc.2015.0005510.3389/fonc.2015.00055 ↗
6. 10.1038/nature1128710.1038/nature11287 ↗
7. 10.3171/2011.8.JNS1155910.3171/2011.8.JNS11559 ↗
8. Jenkinson MD, Barone DG, Bryant A, et al. Intraoperative imaging technology to maximise extent of resection for glioma. Cochrane Database Syst Rev. 2018;1:CD012788.
9. 10.1093/ons/opz13910.1093/ons/opz139 ↗
10. 10.1016/j.pdpdt.2019.05.01310.1016/j.pdpdt.2019.05.013 ↗
11. 10.1016/j.pdpdt.2014.08.00110.1016/j.pdpdt.2014.08.001 ↗
12. 10.1126/science.110427410.1126/science.1104274 ↗
13. 10.1021/nl052405t10.1021/nl052405t ↗
14. 10.1109/TNB.2009.201654810.1109/TNB.2009.2016548 ↗
15. 10.1021/nn700176a10.1021/nn700176a ↗
16. 10.1166/jnn.2015.981010.1166/jnn.2015.9810 ↗
17. 10.1007/s00109-004-0629-x10.1007/s00109-004-0629-x ↗
18. 10.1021/nl034733410.1021/nl0347334 ↗
19. 10.1166/jbn.2013.156110.1166/jbn.2013.1561 ↗
20. 10.1016/j.addr.2012.10.00210.1016/j.addr.2012.10.002 ↗
21. 10.1021/nl801596a10.1021/nl801596a ↗
22. 10.1073/pnas.111140510810.1073/pnas.1111405108 ↗
23. 10.1016/j.biomaterials.2007.06.01110.1016/j.biomaterials.2007.06.011 ↗
24. 10.1126/scitranslmed.300359410.1126/scitranslmed.3003594 ↗
25. 10.3389/fnins.2017.0008610.3389/fnins.2017.00086 ↗
26. 10.2217/nnm.12.20910.2217/nnm.12.209 ↗
27. 10.1038/nrc72710.1038/nrc727 ↗
28. 10.1021/mp400751g10.1021/mp400751g ↗
29. 10.1021/jm970107610.1021/jm9701076 ↗
30. 10.1007/s11095-015-1689-z10.1007/s11095-015-1689-z ↗
31. 10.1160/TH10-11-070110.1160/TH10-11-0701 ↗
32. 10.1016/bs.apha.2014.06.00210.1016/bs.apha.2014.06.002 ↗
33. 10.1016/j.ultras.2008.04.00410.1016/j.ultras.2008.04.004 ↗
34. 10.2174/13816121280009994610.2174/138161212800099946 ↗
35. 10.1517/17425247.5.10.112110.1517/17425247.5.10.1121 ↗
36. 10.1016/j.biomaterials.2016.05.02810.1016/j.biomaterials.2016.05.028 ↗
37. 10.2147/IJN.S6128810.2147/IJN.S61288 ↗
38. 10.1517/17425247.2013.78798710.1517/17425247.2013.787987 ↗
39. 10.1121/1.364690510.1121/1.3646905 ↗
40. 10.1007/s00441-002-0651-710.1007/s00441-002-0651-7 ↗
41. 10.1016/j.jconrel.2016.01.01510.1016/j.jconrel.2016.01.015 ↗
42. 10.1016/j.jconrel.2004.01.01010.1016/j.jconrel.2004.01.010 ↗
43. 10.1002/brb3.41410.1002/brb3.414 ↗
44. 10.2298/VSP121016044R10.2298/VSP121016044R ↗
45. 10.1007/s11060-016-2171-410.1007/s11060-016-2171-4 ↗
46. 10.3171/2011.10.FOCUS1125210.3171/2011.10.FOCUS11252 ↗
47. 10.1016/j.ultrasmedbio.2007.11.00910.1016/j.ultrasmedbio.2007.11.009 ↗
48. 10.1016/j.ultrasmedbio.2007.12.01510.1016/j.ultrasmedbio.2007.12.015 ↗
49. 10.1097/00006123-199805000-0008210.1097/00006123-199805000-00082 ↗
50. Hynynen K, McDannold N, Vykhodtseva N, et al. Non-invasive opening of BBB by focused ultrasound. Acta Neurochir Suppl. 2003;86:555–558.
51. 10.1021/mp060049x10.1021/mp060049x ↗
52. 10.2967/jnumed.107.04945210.2967/jnumed.107.049452 ↗
53. 10.3109/0363904090352098310.3109/03639040903520983 ↗
54. Homayouni A, Sadeghi F, Nokhodchi A, et al. Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers. Iran J Basic Med Sci. 2014;17(5):322–331.
55. Liu Q, Zheng C, Zhao H, et al. Tumor cell pH detection based on fluorescence characteristics of CdSe quantum dots. Technol Health Care. 2019;27(5930):1–9.
56. 10.1016/j.clinbiochem.2007.05.01810.1016/j.clinbiochem.2007.05.018 ↗
57. 10.1016/j.addr.2008.03.01510.1016/j.addr.2008.03.015 ↗
58. 10.1371/journal.pone.012491610.1371/journal.pone.0124916 ↗
59. 10.1016/j.scitotenv.2017.12.33410.1016/j.scitotenv.2017.12.334 ↗
60. 10.1021/acsami.7b0368210.1021/acsami.7b03682 ↗
61. 10.1016/j.jconrel.2017.04.00610.1016/j.jconrel.2017.04.006 ↗
62. 10.18632/oncotarget.1797610.18632/oncotarget.17976 ↗
63. 10.1006/taap.1996.003310.1006/taap.1996.0033 ↗
64. 10.1016/j.ijbiomac.2017.09.03910.1016/j.ijbiomac.2017.09.039 ↗
65. 10.1002/wnan.148310.1002/wnan.1483 ↗